Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients [7]

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 5, 1996, Pages 1040-1042

  Guglielmo, B J ^a   Quan, L A ^a   Stulbarg, M S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; TOBRAMYCIN;

AREA UNDER THE CURVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; RANDOMIZED CONTROLLED TRIAL;

CROSS-OVER STUDIES; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; PILOT PROJECTS; TIME FACTORS; TOBRAMYCIN;

EID: 0029891712     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.5.1040     Document Type: Letter

References (0)